NASDAQ · Medical - Specialties

Edap Tms S.a. (EDAP) Stock

$4.76 -0.52% NASDAQ: EDAP Healthcare

EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments.

Valuation

MetricValue
Price$4.76
Market Cap$178.23M
P/E Ratio-6.63
P/B Ratio20.17
P/S Ratio2.75
EPS (TTM)$-0.78
52-Week High$5.05
52-Week Low$1.21
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-137.53%
ROA-42.70%
ROCE-74.39%
Gross Margin43.42%
Operating Margin-34.67%
Net Margin-41.50%
Debt/Equity2.75
Current Ratio1.34

Annual Financials (USD)

Metric20212022202320242025
Revenue$44.0M$55.0M$60.0M$64.0M$71.0M
Operating Profit$-2.0M$-4.0M$-20.0M$-21.0M$-25.0M
Net Profit$1.0M$-3.0M$-21.0M$-19.0M$-29.0M
EPS$0.02$-0.09$-0.57$-0.51$-0.78
Op Margin-3.7%-7.7%-32.8%-32.0%-35.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$77.0M$101.0M$92.0M$86.0M$79.0M
Total Liabilities$27.0M$29.0M$35.0M$45.0M$60.0M
Cash$47.0M$63.0M$43.0M$30.0M$17.0M
Borrowings$10.0M$9.0M$8.0M$14.0M$28.0M

Latest News

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading MT Newswires · Jul 2, 2026 FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients GlobeNewswire · Jun 30, 2026 European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading MT Newswires · Jun 29, 2026 European Equities Traded in US as ADRs Rise in Thursday Trading MT Newswires · Jun 25, 2026 European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading MT Newswires · Jun 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$4.0M$-3.0M$-15.0M$-14.0M$-16.0M
Investing Cash Flow$-3.0M$-5.0M$-9.0M$-8.0M$-11.0M
Financing Cash Flow$0$1.0M$0$0$0
Net Cash Flow$22.0M$16.0M$-20.0M$-14.0M$-11.0M
Free Cash Flow$3.0M$-5.0M$-19.0M$-18.0M$-22.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.11
EV / EBITDA-8.80
FCF Yield-7.10%
Quick Ratio0.99
Interest Coverage-5.30
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACRV $1.73 +2.37% -0.95 $74.05M 0.00%
FBIO $2.67 -3.61% 0.91 $88.69M 0.00%
HYPR $0.94 +0.99% -3.44 $78.94M 0.00%
INCR $0.90 -6.52% -1.37 $51.61M 0.00%
LUNG $1.22 +4.27% -1.23 $51.53M 0.00%

About Edap Tms S.a.

EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters. This segment also sells spare parts and disposables, such as electrodes. The Distribution segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing and sales channels, as well as through third-party distributors and agents. The company serves academic, public, and private hospitals as well as urology clinics. EDAP TMS S.A. was incorporated in 1979 and is based in Vaulx-en-Velin, France.

Edap Tms S.a. is headquartered in FR.

Edap Tms S.a. (EDAP) stock trades at $4.76 with a market capitalization of $178.23M. The stock is valued at a price-to-earnings (P/E) ratio of -6.63, price-to-book of 20.17, price-to-sales of 2.75. Over the past 52 weeks the stock has ranged between $1.21 and $5.05, and currently trades 5.7% below its 52-week high.

On profitability, Edap Tms S.a. generates a return on equity (ROE) of -137.53%, return on capital employed of -74.39%, an operating margin of -34.67%, a net profit margin of -41.50%.

Official website: focalone.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides